Evidence map›Paper›PMID 39311316›Full record

ArticleVision (Basel, Switzerland)2024

Diabetic Retinopathy Features Segmentation without Coding Experience with Computer Vision Models YOLOv8 and YOLOv9.

Nicola Rizzieri, Luca Dall'Asta, Maris Ozoliņš

Abstract read
In one paragraph

Article in Vision (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Nicola RizzieriDepartment of Optometry and Vision Science, Faculty of Physics, Mathematics and Optometry, University of Latvia, Jelgavas Street 1, LV-1004 Riga, Latvia.ORCID 0009-0003-6189-4255
Luca Dall'AstaResearch and Development, LIFE Srl, IT-70100 Bari, Italy.ORCID 0000-0002-6700-6701
Maris OzoliņšDepartment of Optometry and Vision Science, Faculty of Physics, Mathematics and Optometry, University of Latvia, Jelgavas Street 1, LV-1004 Riga, Latvia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Computer vision is a powerful tool in medical image analysis, supporting the early detection and classification of eye diseases. Diabetic retinopathy (DR), a severe eye disease secondary to diabetes, accompanies several early signs of eye-threatening conditions, such as microaneurysms (MAs), hemorrhages (HEMOs), and exudates (EXs), which have been widely studied and targeted as objects to be detected by computer vision models. In this work, we tested the performances of the state-of-the-art YOLOv8 and YOLOv9 architectures on DR fundus features segmentation without coding experience or a programming background. We took one hundred DR images from the public MESSIDOR database, manually labelled and prepared them for pixel segmentation, and tested the detection abilities of different model variants. We increased the diversity of the training sample by data augmentation, including tiling, flipping, and rotating the fundus images. The proposed approaches reached an acceptable mean average precision (mAP) in detecting DR lesions such as MA, HEMO, and EX, as well as a hallmark of the posterior pole of the eye, such as the optic disc. We compared our results with related works in the literature involving different neural networks. Our results are promising, but far from being ready for implementation into clinical practice. Accurate lesion detection is mandatory to ensure early and correct diagnoses. Future works will investigate lesion detection further, especially MA segmentation, with improved extraction techniques, image pre-processing, and standardized datasets.

Indexed as

computer visiondiabetic retinopathyretinal fundussegmentationYOLOv8YOLOv9

Identifiers

PMID39311316
PMCPMC11417923

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.